Acromegaly with Normal Growth Hormone Levels: Response to Sandostatin-LAR Treatment.
- Published in:
- Pituitary, 2000, v. 2, n. 4, p. 289, doi. 10.1023/A:1009965201451
- By:
- Publication type:
- Article
Works matching IS 1386341X AND DT 2000 AND VI 2 AND IP 4
Results: 7
1
2
Pituitary Lymphoma: A Case Report and Literature Review.
- Published in:
- Pituitary, 2000, v. 2, n. 4, p. 283, doi. 10.1023/A:1009969417380
- By:
- Publication type:
- Article
3
Cabergoline as a First-Line Treatment in Newly Diagnosed Macroprolactinomas.
- Published in:
- Pituitary, 2000, v. 2, n. 4, p. 277, doi. 10.1023/A:1009913200542
- By:
- Publication type:
- Article
4
Efficacy and Tolerability of the Long-Acting Somatostatin Analog Lanreotide in Acromegaly. A 12-Month Multicenter Study of 58 Acromegalic Patients.
- Published in:
- Pituitary, 2000, v. 2, n. 4, p. 269, doi. 10.1023/A:1009961116472
- By:
- Publication type:
- Article
5
Transsphenoidal Surgery for Pituitary Gigantism and Galactorrhea in a 3.5 Year Old Child.
- Published in:
- Pituitary, 2000, v. 2, n. 4, p. 261, doi. 10.1023/A:1009909132401
- By:
- Publication type:
- Article
6
Expression of Leukemia Inhibitory Factor in Human Pituitary Adenomas: A Morphologic and Immunocytochemical Study.
- Published in:
- Pituitary, 2000, v. 2, n. 4, p. 245, doi. 10.1023/A:1009917731493
- By:
- Publication type:
- Article
7
The Effects of a Continuous Infusion of Hexarelin on Pulsatile Growth Hormone Release, Growth Axis and Galanin Gene Expression and on the Response of the Growth Axis to Growth Hormone-Releasing Hormone.
- Published in:
- Pituitary, 2000, v. 2, n. 4, p. 253, doi. 10.1023/A:1009957015563
- By:
- Publication type:
- Article